Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adenosine Diphosphate Ribose × Gynecologic × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1

Interventions

pembrolizumab 34 Paclitaxel 30 Specimen Handling 29 Carboplatin 28 Bevacizumab 25 Magnetic Resonance Spectroscopy 24 olaparib 21 Biopsy 18 Cisplatin 14 Gemcitabine 13 Taxes 10 liposomal doxorubicin 9 Nivolumab 9 Cyclophosphamide 9 Doxorubicin 8 lenvatinib 7 Fulvestrant 7 Drug Therapy 7 niraparib 6 X-Rays 6 Topotecan 6 Radiotherapy 6 Platinum 6 trastuzumab deruxtecan 5 palbociclib 5 fludarabine 5 aldesleukin 5 abemaciclib 5 Oxaliplatin 5 Letrozole 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05494580 2026-03-10

Pamiparib Plus Surufatinib in Patients With Platinum-resistant Ovarian Cancer

Sun Yat-sen University

Phase 1/2 Completed

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡